The current budget proposal calls for allowing Medicare beneficiaries to make contributions to HSA
In President Donald Trump’s 2020 proposed budget, it would allow Medicare beneficiaries to contribute to health savings account. This is
Read moreLegislative Update
HIPAA proposal would move us closer to coordinated care
(By David Friend for STAT) While many people were paying attention to drug pricing, a proposal to update the Health
Read moreThere’s A New ‘Medicare-For-All’ Bill In The House. Why Does It Matter?
(By Shefali Luthra for Kaiser Health News) Members of the House on Wednesday offered their version of a “Medicare-for-all” bill
Read moreTalk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
(By Jay Hancock for Kaiser Health News) Kenneth Frazier, CEO of pharma giant Merck, is set to face senators Tuesday
Read moreTexans Can Appeal Surprise Medical Bills, But The Process Can Be Draining
(By Ashley Lopez, KUT, for Kaiser Health News) In Texas, a growing number of patients are turning to a little-known
Read moreWinners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
(By Jay Hancock for Kaiser Health News) Few consumers have heard of the secret, business-to-business payments that the Trump administration
Read moreCongress Wades Into Emotional Debate Over High-Cost Prescription Drugs
(By Emmarie Huetteman and Rachel Bluth for Kaiser Health News) Senators railed against pharmaceutical executives Tuesday for declining to testify
Read moreAs Congress returns, lawmakers rush to detail drug-pricing agendas
(By Lev Facher for STAT) WASHINGTON — Chuck Grassley wasted little time this week in unveiling his drug-pricing agenda, attaching his
Read moreMedicaid ‘Buy-In’ Could Be a New Health Care Option for the Uninsured
(By Michael Ollove for Stateline, an initiative of The Pew Charitable Trusts) Even as calls for “Medicare for All” grow
Read moreHow PhRMA finally lost: the inside story of the group’s biggest lobbying failure in years
(By Nicholas Florko for STAT) WASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news — and with
Read more